BQCIS

Achieving and Maintaining Global Medical Device Regulatory Approval

Compliance with evolving device regulations—such as the FDA QSR and EU MDR 2017/745—demands a certified ISO 13485 QMS and rigorous oversight from design through post-market surveillance.

BQCIS provides auditing, testing, and advisory support to ensure your medical devices meet global regulatory, technical, and clinical requirements. We help you establish robust systems for design control, documentation, and CAPA management that stand up to regulatory scrutiny.

Our services cover all device classes and include full technical-file preparation and QMS alignment for FDA 510(k) and CE Mark submissions—reducing risk and accelerating global market entry.

Key Medical Device Regulatory Services

ISO 13485 Certification & Gap Analysis

Audits and remediation planning to align your QMS with ISO 13485:2016 and related standards such as ISO 14971 Risk Management. BQCIS identifies deficiencies, develops documentation, and supports certification to meet global market prerequisites.

EU MDR 2017/745 Transition & Technical Documentation

Guidance for MDR compliance, including preparation of Technical Files and Clinical Evaluation Reports (CER), plus post-market surveillance and vigilance systems to ensure continuous conformity after CE Mark approval.

Key Benefits of Medical Device Compliance

Access

Global Market Access

Achieve CE Mark and FDA 510(k) approvals with full regulatory documentation and certification readiness.

Efficiency

Streamlined Certification

Accelerate approvals through structured QMS implementation and proactive regulatory alignment.

Compliance

Regulatory Confidence

Demonstrate full conformity with MDR and ISO standards through traceable, auditable documentation.

Sustainability

Sustained Compliance

Ensure lifecycle compliance via continuous surveillance, vigilance reporting, and internal audits.

Success Story

MDR Transition Strategy Secures EU Market Access

The Challenge:

A Class II device manufacturer faced tight MDR transition deadlines and lacked resources to update technical and clinical documentation.

Our Solution:

BQCIS performed a QMS gap analysis, rebuilt CERs and Risk Management Files, and implemented MDR-compliant post-market processes.

The Result:

Updated files were accepted by the Notified Body on first review, preventing CE Mark lapse and maintaining uninterrupted EU market access.

View More Case Studies →